Scarica l'app Stockscreener
2.01
0.99%
-0.02
Dopo l'orario di chiusura:
2.01
Alx Oncology Holdings Inc Borsa (ALXO) Ultime notizie
Alx Oncology Holdings Stock Price Forecast. Should You Buy ALXO? - StockInvest.us
ALX Oncology to Present at Upcoming Investor Conferences in September - Yahoo Finance
ALX (ALXO) Stock: Ends Up by 2.26% at $2.04 on the Day; Trading Range: the Near-Term Reference Band Stretches From $1.94 to $2.14 at the CloseMomentum Trade - vinanet.vn
ALX (ALXO) EPS and Revenue: EPS Beats Its Estimate in the Latest Session; Stock Move: Shares Close 0.96% Lower on the DayEarnings Preview - vinanet.vn
HC Wainwright Has Positive View of ALX Oncology Q3 Earnings - MarketBeat
ALX Oncology Holdings Inc (ALXO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Alx oncology CEO Jason Lettmann disposes of $4,303 in shares - Investing.com
Alx oncology CEO Jason Lettmann disposes of $4,303 in shares By Investing.com - Investing.com India
Alx Oncology SVP Shelly Wong sells $1,105 of company stock - Investing.com
ALX Oncology (NASDAQ: ALXO) CEO trims stake for taxes - Stock Titan
Piper Sandler Maintains ALX Oncology(ALXO.US) With Buy Rating, Maintains Target Price $4 - Moomoo
ALXO Q2 2026 Earnings: Narrower-Than-Expected Loss Delivers 17.9% EPS SurpriseEPS Consistency Score - Vinanet
ALX Oncology (ALXO) Holds Near $1.96 as Biotech Stock Consolidates Below ResistanceSingle Stock ETF - dars.gov.et
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
TCG Crossover group (NASDAQ: ALXO) reports 4.2% ALX Oncology stake in 13G/A - Stock Titan
ALXO Q2 2026 Earnings: EPS Beat of 17.92% Lifts Shares 4.15%Downward Estimate Revision - Vinanet
Is ALX Oncology Holdings (ALXO) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
H.C. Wainwright Maintains ALX Oncology(ALXO.US) With Buy Rating, Maintains Target Price $4 - Moomoo
ALX Oncology Holdings Inc reports results for the quarter ended June 30Earnings Summary - TradingView
ALX Oncology Holdings Inc expected to post a loss of 15 cents a shareEarnings Preview - TradingView
ALX Oncology (ALXO) Holds Steady at $2.10 as Shares Consolidate Near Key SupportSell Signal Alerts - vinanet.vn
ALX Oncology (NASDAQ:ALXO) Issues Earnings Results - MarketBeat
ALX Oncology Holdings Inc 2Q 2026: Net loss $17.97M, Diluted EPS $(0.13) — 10-Q Summary - TradingView
ALXO: Q2 2026 net loss narrowed, expenses fell, and cash reserves support operations into 2028 - TradingView
Is ALX Oncology Holdings Inc (ALXO) Turning a Corner After Q2 Ea - GuruFocus
ALX Oncology Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
ALX Oncology Reports Second Quarter 2026 Financial Results and Provides Corporate Update - Investing News Network
ALX Oncology Reports Q2 2026 Net Loss of $18 Million - Quiver Quantitative
ALX Oncology reports Q2 2026 net loss of $18.0M, $153.4M cash; advances evorpacept and ALX2004 - TradingView
ALXO: Reduced net loss, robust cash position, and advancing clinical milestones drive outlook - TradingView
Clinical pipeline accelerates as ALX Oncology posts Q2 results and updates on ALX2004 study - Traders Union
ALXO Q2'26 Earnings: EPS estimate is (0.14) USD - TradingView
ALX Oncology (ALXO) Projected to Post Earnings on Tuesday - MarketBeat
ALX Oncology Holdings (ALXO) Holds Steady Near $1.94 as Biotech Sector Watches Key LevelsUnusual Call Volume - dars.gov.et
Vivo Capital LLC Buys Shares of 3,184,713 ALX Oncology Holdings Inc. $ALXO - MarketBeat
ALXO Q2'26 Earnings: revenue estimate is 0 USD - TradingView
Redmile Group LLC Acquires 4,699,470 Shares of ALX Oncology Holdings Inc. $ALXO - MarketBeat
ALX Oncology Holdings Inc (ALXO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
ALX Oncology Holdings Inc. $ALXO Stock Position Boosted by venBio Partners LLC - MarketBeat
BlackRock (NYSE: BLK) reports 5.4% passive stake in ALX Oncology (ALXO) - Stock Titan
ALX Oncology Holdings Inc (ALXO) Cash Flow - TradingKey
2,866,256 Shares in ALX Oncology Holdings Inc. $ALXO Purchased by Orbimed Advisors LLC - MarketBeat
ALX Oncology Holdings Inc (ALXO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
ALXO|ALX Oncology Holdings Inc|Price:2.030|Chg%:+0.010 - TradingKey
ALX Oncology Holdings Inc (ALXO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
ALXO|ALX Oncology Holdings Inc|Price:2.020|Chg%:-0.010 - TradingKey
TradingKey - TradingKey
ALX Oncology Holdings Inc. Revenue Breakdown – NASDAQ:ALXO - TradingView
ALX Oncology Holdings Inc (ALXO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Alx Oncology Holdings, Inc. (ALXO) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
Alx Oncology Holdings, Inc. (ALXO) Q2 2025 Earnings ReportResults, Call & Slides - TipRanks
Alx Oncology Holdings, Inc. (ALXO) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks
ALX Oncology (ALXO) Status Update Summary - Quartr
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
ALXO Q1 2026 Earnings: Smaller-than-Expected Loss Boosts SharesProfit Recovery Report - vinanet.vn
ALXO Q1 2026 Earnings: Narrower Loss Beats Estimates as Pipeline Progress ContinuesCEO Earnings Statement - vinanet.vn
ALXO Q1 2026 Earnings: Narrower-Than-Expected Loss as Pipeline Development ContinuesRevenue Surprise History - vinanet.vn
BIAF Stock Plunges 77% in 3 Months: Should You Still Hold or Sell? - The Globe and Mail
ALXO Q1 2026 Earnings: Narrower-than-Expected Loss Highlights Cost DisciplineEstimate Uncertainty - dars.gov.et
ALX Oncology (ALXO) Jefferies London Healthcare Conference 2025 Summary - Quartr
ALX Oncology (ALXO) SVP sells 1,404 shares for RSU tax obligations - Stock Titan
ALXOAlx Oncology Holdings Inc Options - Finviz
0.86%
0.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):